'The long-awaited acquisition': Eurobio to buy GenDx, shares rise

Eurobio Scientific SA

18/08/2022 08:20

** Shares in Eurobio Scientific  ALERS.PA  rise 4.3% after
the France-based biotech company said it would acquire the Dutch
company Genome Diagnostics (GenDx)  urn:newsml:reuters.com:*:nFWN2ZT5F8
    ** The group says it signed a deal to buy 100% of the
capital and the voting rights of GenDx for EUR 135 million 
($137 million), a transaction to take place by mid-October
    ** Midcap Partners points to "the long-awaited acquisition"
of GenDx and its portfolio of 100% proprietary products, which
"fits perfectly into Eurobio's new strategy"
    ** The stock of Eurobio is down around 27% year-to-date


($1 = 0.9846 euros)

 (Reporting by Juliette Portala)
 ((juliette.portala@tr.com))